| Literature DB >> 35602841 |
Hatem Najar1, Laurene Tuider1, Vinita Kukkar2, Mohammad Quasem3.
Abstract
Thrombotic microangiopathy (TMA) is a serious and potentially fatal disorder, especially if there is a delay in diagnosis and appropriate treatment. Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS) are the two main forms of TMA. Although severe acute kidney injury (AKI) is a common manifestation of TMA, it remains rarely described in reported TTP cases. We present a rare case of TTP in a 76-year-old African American male who presented with severe AKI (stage 3) and uremic symptoms. Early diagnosis and prompt treatment of TTP with plasmapheresis followed by rituximab and caplacizumab were associated with the resolution of the AKI and avoidance of hemodialysis. This case highlights the need to consider TTP as a possible diagnosis even in the setting of severe AKI.Entities:
Keywords: acute kidney injury; therapeutic plasmapheresis; thrombocytopenia; thrombotic microangiopathy (tma); thrombotic thrombocytopenic purpura
Year: 2022 PMID: 35602841 PMCID: PMC9113771 DOI: 10.7759/cureus.24221
Source DB: PubMed Journal: Cureus ISSN: 2168-8184